Benign neoplasm: Connective and other soft tissue of head, face and neck

CD2_BENIGN_CONNSOFT_HEADFACETRUNK

head and neck malignant neoplasia: A primary or metastatic malignant neoplasm affecting the head and neck. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 D21.0&

Hospital discharge: ICD-9 2150

Hospital discharge: ICD-8 21501

Cause of death: ICD-10 D21.0&

Cause of death: ICD-9 2150

Cause of death: ICD-8 21501

661

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

378

Check minimum number of events None

378

Include endpoints None

378

CD2_BENIGN_CONNSOFT_HEADFACETRUNK

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D21

Name in latin Neoplasma benignum textus connectivi capitis/faciei

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Connective and other soft tissue of head, face and neck based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

All

Female

Male

Number of individuals

368

190

178

Unadjusted prevalence (%)

0.12

0.11

0.13

Mean age at first event (years)

42.59

38.62

46.83

?

Follow-up

Amount of time to look for the endpoint since entering the study. This is either either 1, 5, 15 years or the full study time from 1998 to 2019.

Absolute risk

Estimates the probability of dying from the current endpoint. Check the Documentation page for Mortality: absolute risk to get more details.

Hazard Ratio (HR) and 95% Confidence Interval (CI)

Measures how much the risk of dying increases (HR > 1) or decreases (HR < 1).

Number of individuals (N)

Number of individuals having the current endpoint and died during the follow-up time.
Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.02	1.60 [0.84, 3.03]	1.5e-1	34
15 years	0.01	1.18 [0.64, 2.17]	6.0e-1	20
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_CONNSOFT_HEADFACETRUNK – Benign neoplasm: Connective and other soft tissue of head, face and neck
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Benign neoplasm: Connective and other soft tissue of head, face and neck
after Benign neoplasm: Connective and other soft tissue of head, face and neck

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Benign neoplasm: Connective and other soft tissue of head, face and neck

↥